Pre-diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sign the informed consent form; 2. in line with the pre-diabetes diagnostic criteria, and syndrome differentiation for the spleen and stomach stagnation syndrome patients; 3. aged 18-70 years old.
Exclusion criteria
Exclusion criteria: 1. Those who have used hypoglycemic drugs and insulin therapy in the past; 2. Cardiovascular events (cerebral vascular accidents in the past 6 months, myocardial infarction or heart failure; those with severe organic heart disease; those with aortic aneurysm or dissection aneurysm; specific angina, type II Ventricular conduction block, sick sinus syndrome); 3. Impaired liver and kidney function: AST and / or ALT is equal to or greater than 2 times the upper limit of normal; creatinine is equal to or greater than the upper limit of normal. Urine protein > ++ and / or hematuria; 4. People with endocrine diseases (such as hyperthyroidism), autoimmune diseases, cancer or other serious fatal diseases; 5. Those who have used glucocorticoids, beta blockers, thiazide diuretics and niacin; 6. Pregnancy, pregnancy or lactation women; 7. Psychiatric patients or non-cooperative patients; 8. Patients who have participated in other drug clinical trials or are participating in other clinical trials within one month prior to the trial; 9. Those who are known to be allergic to traditional Chinese medicine ingredients; 10. After blood pressure is uncontrolled or controlled, SBP>160mmHg, DBP>100mmHg and those with secondary hypertension; 11. Alcohol and/or psychoactive substances, drug abusers and dependents in the past 5 years; 12. According to the judgment of the investigator, other lesions or conditions that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in the working environment and unstable living environment, may cause loss of follow-up; 13. It is known that there is no feeling for hypoglycemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Type 2 diabetes incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c;Islet function;Glucose tolerance test;Syndrome points; | — |
Countries
China
Contacts
Gansu Provincial Hospital of TCM